Quanterix CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
QTRX
Quanterix CORPQuanterix Corporation has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 9, 2026, with key proposals including director elections and equity plan amendments.
NASDAQ
QTRX
Quanterix CORPQuanterix Corporation adjourned its 2025 Annual Meeting of Stockholders to allow more time for voting on proposals to eliminate supermajority voting requirements.
NASDAQ
QTRX
Quanterix CORPQuanterix Corporation will hold its 2025 annual meeting to vote on board declassification, executive compensation, and auditor ratification, following recent board changes and financial restatements.
NASDAQ
QTRX
Quanterix CORPDEFC14A: Kent Lake Urges Quanterix Stockholders to Vote Against Proposed Merger with Akoya Biosciences
Kent Lake Partners, owning 7.7% of Quanterix, is soliciting proxies to vote against the proposed merger with Akoya Biosciences, believing it is not in the best interests of Quanterix stockholders.
NASDAQ
QTRX
Quanterix CORPQuanterix Corporation will hold its annual stockholder meeting on June 3, 2024, to vote on the election of directors, executive compensation, and the ratification of Ernst & Young LLP as the independent accounting firm.
NASDAQ
QTRX
Quanterix CORPQuanterix Corporation has scheduled its 2024 annual meeting of stockholders for June 3, 2024, to elect directors, approve executive compensation, and ratify the appointment of its independent accounting firm.